(Q36134838)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908902%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

review article

1 reference

title

Reduction of caregiver burden in Alzheimer's disease by treatment with galantamine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908902%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

0 references

Daniel I Kaufer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908902%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Soo Borson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908902%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Peter Kershaw

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908902%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Kay Sadik

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908902%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

1 reference

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908902%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908902%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908902%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908902%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

481-488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908902%20AND%20SRC:MED&resulttype=core&format=json

Caregiver time use: an outcome measure in clinical trial research on Alzheimer's disease

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

The economic burden of Alzheimer's disease care

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Acetylcholine release in the rat hippocampus as measured by the microdialysis method correlates with motor activity and exhibits a diurnal variation

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

EEG sleep in elderly depressed, demented, and healthy subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Determinants of carer stress in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

The effects of galantamine treatment on caregiver time in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

The impact of symptom severity on the cost of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Cognitive function and the costs of Alzheimer disease. An exploratory study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Predictive validity of factors influencing the institutionalization of elderly people with psycho-geriatric disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Caregiving as a risk factor for mortality: the Caregiver Health Effects Study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

National estimates of the quantity and cost of informal caregiving for the elderly with dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Families caring for elders in residence: issues in the measurement of burden

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Alzheimer Disease in the US Population

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

The everyday impacts of providing informal care to dependent elders and their consequences for the care recipients.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

The psychological and physical health of family members caring for an elderly person with dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Caregiver well-being: a multidimensional examination of family caregivers of demented adults.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

To what degree does cognitive impairment in Alzheimer's disease predict dependence of patients on caregivers?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Co-Use of Donepezil and Hypnotics Among Alzheimer's Disease Patients Living in the Community

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

The costs of family contributions to the care of persons with dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Symposium: Cognitive processes and sleep disturbances: Sleep/wake patterns in Alzheimer's disease: relationships with cognition and function.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Economic impact of Alzheimer's disease in the United Kingdom. Cost of care and disease severity for non-institutionalised patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

A comparison of employed caregivers of cognitively impaired and physically impaired elderly persons

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Galantamine: therapeutic effects beyond cognition

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Caregivers of the frail elderly: a national profile

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Alzheimer's disease. The unpaid burden of caring

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Behavioral and psychiatric manifestations in dementia patients in a community: caregiver burden and outcome.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Accelerated risk of hypertensive blood pressure recordings among Alzheimer caregivers

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

The family caregiver's role in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Timing of sleep and wakefulness in Alzheimer's disease patients residing at home

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Predictors of institutionalization among caregivers of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Prevalence and impact of caregiving: a detailed comparison between dementia and nondementia caregivers.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

The US economic and social costs of Alzheimer's disease revisited

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Sleep complaints in older women who are family caregivers

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900023178

7 January 2021

10.1017/S1092852900023178

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15908902%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference